Azechi, T.; Fukaya, Y.; Nitani, C.; Hara, J.; Kawamoto, H.; Taguchi, T.; Yoshimura, K.; Sato, A.; Hattori, N.; Ushijima, T.;
et al. Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors. Curr. Oncol. 2024, 31, 7155-7164.
https://doi.org/10.3390/curroncol31110527
AMA Style
Azechi T, Fukaya Y, Nitani C, Hara J, Kawamoto H, Taguchi T, Yoshimura K, Sato A, Hattori N, Ushijima T,
et al. Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors. Current Oncology. 2024; 31(11):7155-7164.
https://doi.org/10.3390/curroncol31110527
Chicago/Turabian Style
Azechi, Takuya, Yutaka Fukaya, Chika Nitani, Junichi Hara, Hiroshi Kawamoto, Tomoaki Taguchi, Kenichi Yoshimura, Akihiro Sato, Naoko Hattori, Toshikazu Ushijima,
and et al. 2024. "Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors" Current Oncology 31, no. 11: 7155-7164.
https://doi.org/10.3390/curroncol31110527
APA Style
Azechi, T., Fukaya, Y., Nitani, C., Hara, J., Kawamoto, H., Taguchi, T., Yoshimura, K., Sato, A., Hattori, N., Ushijima, T., & Kimura, T.
(2024). Population Pharmacokinetics of Tamibarotene in Pediatric and Young Adult Patients with Recurrent or Refractory Solid Tumors. Current Oncology, 31(11), 7155-7164.
https://doi.org/10.3390/curroncol31110527
